Baillieu Holst Research

November 25, 2019

First-in-Class mAb Oncology Program Will Rerate the Stock; Lots of Room to Grow for Advangen; New Target Price of 8.4c

November 25, 2019

It’s rare for a company to own a whole new target this big

November 25, 2019

Australian Life Sciences

November 25, 2019

It’s rare for one company to own a whole new target this big

Shop évolis®